TP53 and gastric cancer: Gene therapy with a replicative oncolytic adenovirus-expressing wild-type p53 gene (OBP-702) against CAFs and peritoneal metastases in gastric cancer (GC) resulted in cytotoxicity to both gastric cancer cells and CAFs but not to normal gastric fibroblasts in a murine model [547].